These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31287730)

  • 1. Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines.
    Sousa DP; Pojo M; Pinto AT; Leite V; Serra AT; Cavaco BM
    Nutr Cancer; 2020; 72(2):352-363. PubMed ID: 31287730
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells.
    Allegri L; Domenis R; Navarra M; Celano M; Russo D; Capriglione F; Damante G; Baldan F
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34318905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nutraceuticals on anaplastic thyroid cancer cells.
    Allegri L; Rosignolo F; Mio C; Filetti S; Baldan F; Damante G
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):285-294. PubMed ID: 29197967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.
    Mehta A; Zhang L; Boufraqech M; Zhang Y; Patel D; Shen M; Kebebew E
    Endocr Relat Cancer; 2015 Jun; 22(3):319-29. PubMed ID: 25972243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
    Yan P; Su Z; Zhang Z; Gao T
    Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells.
    Wang W; Zhou J; Zhao L; Chen S
    Biomed Pharmacother; 2017 Apr; 88():985-990. PubMed ID: 28178630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of melatonin on the toxicity and proliferation of human anaplastic thyroid cancer cell line.
    Ghorbani-Anarkooli M; Dabirian S; Zendedel A; Moladoust H; Bahadori MH
    Acta Histochem; 2021 Apr; 123(3):151700. PubMed ID: 33667778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.
    Liu J; Feng L; Zhang H; Zhang J; Zhang Y; Li S; Qin L; Yang Z; Xiong J
    Cancer Biol Ther; 2018 Jun; 19(6):484-496. PubMed ID: 29504819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells.
    Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A
    Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines.
    Lopes-Ventura S; Pojo M; Matias AT; Moura MM; Marques IJ; Leite V; Cavaco BM
    J Endocrinol Invest; 2019 May; 42(5):527-540. PubMed ID: 30191474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
    Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status.
    Ishihara S; Onoda N; Noda S; Asano Y; Tauchi Y; Morisaki T; Kashiwagi S; Takashima T; Ohira M
    Int J Oncol; 2019 Nov; 55(5):1069-1076. PubMed ID: 31545405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic inhibition of polo-like kinases in anaplastic thyroid cancer.
    Lin SF; Yeh CN; Huang YT; Chou TC; Wong RJ
    Cancer Sci; 2021 Feb; 112(2):803-814. PubMed ID: 33306266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway.
    Tong AH; Tan J; Zhang JH; Xu FJ; Li FY; Cao CY
    J Biochem Mol Toxicol; 2019 Feb; 33(2):e22241. PubMed ID: 30431689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
    Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J
    Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC).
    Abdulghani J; Gokare P; Gallant JN; Dicker D; Whitcomb T; Cooper T; Liao J; Derr J; Liu J; Goldenberg D; Finnberg NK; El-Deiry WS
    Clin Cancer Res; 2016 Dec; 22(24):6192-6203. PubMed ID: 27307592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Kocdor MA; Cengiz H; Ates H; Kocdor H
    Anticancer Agents Med Chem; 2019; 19(15):1887-1898. PubMed ID: 31584382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
    Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
    Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.